Mutational status of EZH2 and CD79B hot spots in mature B-cell non-Hodgkin's lymphomas: novel CD79B variations have been revealed


Cetin G. O., Baris I. C., Caner V., Sarikepe B., Sen Turk N., Tepeli E., ...More

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.20, no.5, pp.830-836, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 5
  • Publication Date: 2016
  • Journal Name: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.830-836
  • Keywords: EZH2, CD79B, Mature B-cell non-Hodgkin lymphoma, Mutation, CHRONIC LYMPHOCYTIC-LEUKEMIA, CLASSIFICATION, MALIGNANCIES, METHYLATION, PATHWAY, COMPLEX, PROTEIN
  • Akdeniz University Affiliated: Yes

Abstract

OBJECTIVE: We aimed to determine the hot spot mutational frequencies of Enhancer of Zeste homolog 2 (EZH2) and cluster of differentiation 79B (CD79B) genes in a cohort of mature B-cell non-Hodgkin's lymphomas.